Skip to main content
Erschienen in: Angiogenesis 3/2017

24.01.2017 | Original Paper

A somatic GNA11 mutation is associated with extremity capillary malformation and overgrowth

verfasst von: Javier A. Couto, Ugur M. Ayturk, Dennis J. Konczyk, Jeremy A. Goss, August Y. Huang, Steve Hann, Jennifer L. Reeve, Marilyn G. Liang, Joyce Bischoff, Matthew L. Warman, Arin K. Greene

Erschienen in: Angiogenesis | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Capillary malformation is a cutaneous vascular anomaly that is present at birth, darkens over time, and can cause overgrowth of tissues beneath the stain. The lesion is caused by a somatic activating mutation in GNAQ. In a previous study, we were unable to identify a GNAQ mutation in patients with a capillary malformation involving an overgrown lower extremity. We hypothesized that mutations in GNA11 or GNA14, genes closely related to GNAQ, also may cause capillary malformations.

Methods

Human capillary malformation tissue obtained from 8 patients that had tested negative for GNAQ mutations were studied. Lesions involved an extremity (n = 7) or trunk (n = 1). Droplet digital PCR (ddPCR) was used to detect GNA11 or GNA14 mutant cells (p.Arg183) in the specimens. Single molecule molecular inversion probe sequencing (smMIP-seq) was performed to search for other mutations in GNA11. Mutations were validated by subcloning and sequencing amplimers.

Results

We found a somatic GNA11 missense mutation (c.547C > T; p.Arg183Cys) in 3 patients with a diffuse capillary malformation of an extremity. Mutant allelic frequencies ranged from 0.3 to 5.0%. GNA11 or GNA14 mutations were not found in 5 affected tissues or in unaffected tissues (white blood cell DNA).

Conculsions

GNA11 mutations are associated with extremity capillary malformations causing overgrowth. Pharmacotherapy that affects GNA11 signaling may prevent the progression of capillary malformations.
Literatur
1.
Zurück zum Zitat Shirley MD, Tang H, Gallione CJ et al (2013) Sturge–Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med 368:1971–1979CrossRefPubMedPubMedCentral Shirley MD, Tang H, Gallione CJ et al (2013) Sturge–Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med 368:1971–1979CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Nakashima M, Miyajima M, Sugano H et al (2014) The somatic GNAQ mutation c.548G > A (p. R183Q) is consistently found in Sturge–Weber syndrome. J Hum Genet 59:691–693CrossRefPubMed Nakashima M, Miyajima M, Sugano H et al (2014) The somatic GNAQ mutation c.548G > A (p. R183Q) is consistently found in Sturge–Weber syndrome. J Hum Genet 59:691–693CrossRefPubMed
3.
Zurück zum Zitat Couto JA, Huang L, Vivero MP et al (2016) Endothelial cells from capillary malformations are enriched for Somatic GNAQ mutations. Plast Reconstr Surg 137:77e–82eCrossRefPubMedPubMedCentral Couto JA, Huang L, Vivero MP et al (2016) Endothelial cells from capillary malformations are enriched for Somatic GNAQ mutations. Plast Reconstr Surg 137:77e–82eCrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Ayturk UM, Couto JA, Hann S et al (2016) Somatic activating mutations in GNAQ and GNA11 are associated with congenital hemangioma. Am J Hum Genet 98:789–795CrossRefPubMedPubMedCentral Ayturk UM, Couto JA, Hann S et al (2016) Somatic activating mutations in GNAQ and GNA11 are associated with congenital hemangioma. Am J Hum Genet 98:789–795CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Lee MS, Liang MG, Mulliken JB (2013) Diffuse capillary malformation with overgrowth: a clinical subtype of vascular anomalies with hypertrophy. J Am Acad Dermatol 69:589–594CrossRefPubMed Lee MS, Liang MG, Mulliken JB (2013) Diffuse capillary malformation with overgrowth: a clinical subtype of vascular anomalies with hypertrophy. J Am Acad Dermatol 69:589–594CrossRefPubMed
6.
Zurück zum Zitat Lian CG, Sholl LM, Zakka LR et al (2014) Novel genetic mutations in a sporadic port-wine stain. JAMA Dermatol 150:1336–1340CrossRefPubMed Lian CG, Sholl LM, Zakka LR et al (2014) Novel genetic mutations in a sporadic port-wine stain. JAMA Dermatol 150:1336–1340CrossRefPubMed
7.
Zurück zum Zitat Metz CH, Scheulen M, Bornfeld N, Lohmann D, Zeschnigk M (2013) Ultradeep sequencing detects GNAQ and GNA11 mutations in cell-free DNA from plasma of patients with uveal melanoma. Cancer Med 2:208–215CrossRefPubMedPubMedCentral Metz CH, Scheulen M, Bornfeld N, Lohmann D, Zeschnigk M (2013) Ultradeep sequencing detects GNAQ and GNA11 mutations in cell-free DNA from plasma of patients with uveal melanoma. Cancer Med 2:208–215CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Thomas AC, Zeng Z, Riviere JB et al (2016) Mosaic activating mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis. J Invest Dermatol 136:770–778CrossRefPubMedPubMedCentral Thomas AC, Zeng Z, Riviere JB et al (2016) Mosaic activating mutations in GNA11 and GNAQ Are Associated with Phakomatosis Pigmentovascularis and Extensive Dermal Melanocytosis. J Invest Dermatol 136:770–778CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Costa S, Byrne M, Pissaloux D et al (2016) Melanomas associated with blue nevi or mimicking cellular blue nevi: clinical, pathologic, and molecular study of 11 cases displaying a high frequency of GNA11 mutations, BAP1 expression loss, and a predilection for the scalp. Am J Surg Pathol 40:368–377CrossRefPubMed Costa S, Byrne M, Pissaloux D et al (2016) Melanomas associated with blue nevi or mimicking cellular blue nevi: clinical, pathologic, and molecular study of 11 cases displaying a high frequency of GNA11 mutations, BAP1 expression loss, and a predilection for the scalp. Am J Surg Pathol 40:368–377CrossRefPubMed
10.
Zurück zum Zitat Lim YH, Bacchiocchi A, Qiu J et al (2016) GNA14 somatic mutation causes congenital and sporadic vascular tumors by MAPK activation. Am J Hum Genet 99:443–450CrossRefPubMedPubMedCentral Lim YH, Bacchiocchi A, Qiu J et al (2016) GNA14 somatic mutation causes congenital and sporadic vascular tumors by MAPK activation. Am J Hum Genet 99:443–450CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Sivaraj KK, Li R, Albarran-Juarez J et al (2015) Endothelial Galphaq/11 is required for VEGF-induced vascular permeability and angiogenesis. Cardiovasc Res 108:171–180CrossRefPubMed Sivaraj KK, Li R, Albarran-Juarez J et al (2015) Endothelial Galphaq/11 is required for VEGF-induced vascular permeability and angiogenesis. Cardiovasc Res 108:171–180CrossRefPubMed
13.
Zurück zum Zitat Zeng H, Zhao D, Mukhopadhyay D (2002) KDR stimulates endothelial cell migration through heterotrimeric G protein Gq/11-mediated activation of a small GTPase RhoA. J Biol Chem 277:46791–46798CrossRefPubMed Zeng H, Zhao D, Mukhopadhyay D (2002) KDR stimulates endothelial cell migration through heterotrimeric G protein Gq/11-mediated activation of a small GTPase RhoA. J Biol Chem 277:46791–46798CrossRefPubMed
14.
Zurück zum Zitat Zeng H, Zhao D, Yang S, Datta K, Mukhopadhyay D (2003) Heterotrimeric G alpha q/G alpha 11 proteins function upstream of vascular endothelial growth factor (VEGF) receptor-2 (KDR) phosphorylation in vascular permeability factor/VEGF signaling. J Biol Chem 278:20738–20745CrossRefPubMed Zeng H, Zhao D, Yang S, Datta K, Mukhopadhyay D (2003) Heterotrimeric G alpha q/G alpha 11 proteins function upstream of vascular endothelial growth factor (VEGF) receptor-2 (KDR) phosphorylation in vascular permeability factor/VEGF signaling. J Biol Chem 278:20738–20745CrossRefPubMed
Metadaten
Titel
A somatic GNA11 mutation is associated with extremity capillary malformation and overgrowth
verfasst von
Javier A. Couto
Ugur M. Ayturk
Dennis J. Konczyk
Jeremy A. Goss
August Y. Huang
Steve Hann
Jennifer L. Reeve
Marilyn G. Liang
Joyce Bischoff
Matthew L. Warman
Arin K. Greene
Publikationsdatum
24.01.2017
Verlag
Springer Netherlands
Erschienen in
Angiogenesis / Ausgabe 3/2017
Print ISSN: 0969-6970
Elektronische ISSN: 1573-7209
DOI
https://doi.org/10.1007/s10456-016-9538-1

Weitere Artikel der Ausgabe 3/2017

Angiogenesis 3/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.